147 related articles for article (PubMed ID: 14705770)
1. Comparing the relationship of Taxol-based chemotherapy response with P-glycoprotein and lung resistance-related protein expression in non-small cell lung cancer.
Chiou JF; Liang JA; Hsu WH; Wang JJ; Ho ST; Kao A
Lung; 2003; 181(5):267-73. PubMed ID: 14705770
[TBL] [Abstract][Full Text] [Related]
2. Using technetium-99m tetrofosmin chest imaging to predict taxol-based chemotherapy response in non-small cell lung cancer but not related to lung resistance protein expression.
Shih CM; Shiau YC; Wang JJ; Ho ST; Kao A
Lung; 2003; 181(2):103-11. PubMed ID: 12953149
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of chest single photon emission computed tomography with technetium-99m methoxyisobutylisonitrile to predict taxol based chemotherapy response in advanced non-small cell lung cancer.
Shih CM; Hsu WH; Huang WT; Wang JJ; Ho ST; Kao A
Cancer Lett; 2003 Sep; 199(1):99-105. PubMed ID: 12963129
[TBL] [Abstract][Full Text] [Related]
4. To predict response chemotherapy using technetium-99m tetrofosmin chest images in patients with untreated small cell lung cancer and compare with p-glycoprotein, multidrug resistance related protein-1, and lung resistance-related protein expression.
Kuo TH; Liu FY; Chuang CY; Wu HS; Wang JJ; Kao A
Nucl Med Biol; 2003 Aug; 30(6):627-32. PubMed ID: 12900288
[TBL] [Abstract][Full Text] [Related]
5. Predicting chemotherapy response to paclitaxel-based therapy in advanced non-small-cell lung cancer with P-glycoprotein expression.
Yeh JJ; Hsu WH; Wang JJ; Ho ST; Kao A
Respiration; 2003; 70(1):32-5. PubMed ID: 12584388
[TBL] [Abstract][Full Text] [Related]
6. Technetium-99m tetrofosmin chest imaging related to p-glycoprotein expression for predicting the response with paclitaxel-based chemotherapy for non-small cell lung cancer.
Shiau YC; Tsai SC; Wang JJ; Ho YJ; Ho ST; Kao CH
Lung; 2001; 179(4):197-207. PubMed ID: 11891611
[TBL] [Abstract][Full Text] [Related]
7. Predicting chemotherapy response to paclitaxel-based therapy in advanced non-small-cell lung cancer (stage IIIb or IV) with a higher T stage (> T2). Technetium-99m methoxyisobutylisonitrile chest single photon emission computed tomography and P-glycoprotein express ion.
Hsu WH; Yen RF; Kao CH; Shiun SC; Hsu NY; Lin CC; Lee CC
Oncology; 2002; 63(2):173-9. PubMed ID: 12239453
[TBL] [Abstract][Full Text] [Related]
8. Comparison of chemotherapy response with P-glycoprotein, multidrug resistance-related protein-1, and lung resistance-related protein expression in untreated small cell lung cancer.
Yeh JJ; Hsu NY; Hsu WH; Tsai CH; Lin CC; Liang JA
Lung; 2005; 183(3):177-83. PubMed ID: 16078039
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of expression of P53, Bcl-2 and lung resistance-related protein for response to chemotherapy in non-small cell lung cancers.
Harada T; Ogura S; Yamazaki K; Kinoshita I; Itoh T; Isobe H; Yamashiro K; Dosaka-Akita H; Nishimura M
Cancer Sci; 2003 Apr; 94(4):394-9. PubMed ID: 12824911
[TBL] [Abstract][Full Text] [Related]
10. [Predictive value of drug resistance-related genes expression in neoadjuvant chemotherapy in patients with non-small cell lung cancer of stage III].
Peng ZM; Luo J; Wang WB; Wang XH; Chen JH; Lan SM
Ai Zheng; 2004 Aug; 23(8):963-7. PubMed ID: 15301725
[TBL] [Abstract][Full Text] [Related]
11. P-glycoprotein, lung resistance-related protein and multidrug resistance associated protein in de novo acute non-lymphocytic leukaemias: biological and clinical implications.
Michieli M; Damiani D; Ermacora A; Masolini P; Raspadori D; Visani G; Scheper RJ; Baccarani M
Br J Haematol; 1999 Feb; 104(2):328-35. PubMed ID: 10050716
[TBL] [Abstract][Full Text] [Related]
12. Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma.
Izquierdo MA; van der Zee AG; Vermorken JB; van der Valk P; Beliƫn JA; Giaccone G; Scheffer GL; Flens MJ; Pinedo HM; Kenemans P
J Natl Cancer Inst; 1995 Aug; 87(16):1230-7. PubMed ID: 7563169
[TBL] [Abstract][Full Text] [Related]
13. P-glycoprotein (PGP), lung resistance-related protein (LRP) and multidrug resistance-associated protein (MRP) expression in acute promyelocytic leukaemia.
Michieli M; Damiani D; Ermacora A; Geromin A; Michelutti A; Masolini P; Baccarani M
Br J Haematol; 2000 Mar; 108(4):703-9. PubMed ID: 10792272
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of lung-resistance protein and increased P-glycoprotein function in acute myeloid leukaemia cells predict a poor response to chemotherapy and reduced patient survival.
Borg AG; Burgess R; Green LM; Scheper RJ; Yin JA
Br J Haematol; 1998 Dec; 103(4):1083-91. PubMed ID: 9886324
[TBL] [Abstract][Full Text] [Related]
15. Association of expression of MRP1, BCRP, LRP and ERCC1 with outcome of patients with locally advanced non-small cell lung cancer who received neoadjuvant chemotherapy.
Li J; Li ZN; Yu LC; Bao QL; Wu JR; Shi SB; Li XQ
Lung Cancer; 2010 Jul; 69(1):116-22. PubMed ID: 19875192
[TBL] [Abstract][Full Text] [Related]
16. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
[TBL] [Abstract][Full Text] [Related]
17. Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications.
Berger W; Setinek U; Hollaus P; Zidek T; Steiner E; Elbling L; Cantonati H; Attems J; Gsur A; Micksche M
J Cancer Res Clin Oncol; 2005 Jun; 131(6):355-63. PubMed ID: 15856298
[TBL] [Abstract][Full Text] [Related]
18. Expression of MRP1, BCRP, LRP, and ERCC1 in advanced non-small-cell lung cancer: correlation with response to chemotherapy and survival.
Li J; Li ZN; Du YJ; Li XQ; Bao QL; Chen P
Clin Lung Cancer; 2009 Nov; 10(6):414-21. PubMed ID: 19900859
[TBL] [Abstract][Full Text] [Related]
19. Expression of the human major vault protein LRP in human lung cancer samples and normal lung tissues.
Dingemans AM; van Ark-Otte J; van der Valk P; Apolinario RM; Scheper RJ; Postmus PE; Giaccone G
Ann Oncol; 1996 Aug; 7(6):625-30. PubMed ID: 8879378
[TBL] [Abstract][Full Text] [Related]
20. Association of nuclear YB-1 localization with lung resistance-related protein and epidermal growth factor receptor expression in lung cancer.
Hyogotani A; Ito K; Yoshida K; Izumi H; Kohno K; Amano J
Clin Lung Cancer; 2012 Sep; 13(5):375-84. PubMed ID: 22284440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]